WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Anticonvulsant Efficacy Endpoints - v1A, Subtypes include Partial secondarily generalized seizures, Patients suffer from Infantile spasms (IS), Median % change of total seizures assessed during Maintenance phase, Closed Circuit Television Electroencephalography (CCTV-EEG) monitoring is monitored following Spasm freedom, Minimal improvement is quantified by Proportion of patients, Efficacy endpoints include Well-being, Average daily spasm frequency is quantified by % change, Complex partial seizures (CPS) are classified as Type 1B, Closed Circuit Television Electroencephalography (CCTV-EEG) monitoring observes Hypsarrythmia, Closed Circuit Television Electroencephalography (CCTV-EEG) monitoring is recorded for Defined timepoints, Last spasm date is reported by Caregiver, Spasm freedom occuring over Defined timepoints, Diary is classified by Investigator, Efficacy endpoints include Physician global assessment, Potiga is also known as Ezogabine, Potiga are treated with Partial seizures, % change in total partial seizure frequency is assessed between Baseline, Partial secondarily generalized seizures are classified as Type 1C, Subtypes include Complex partial seizures (CPS), Patients can experience Motor function abnormalities